Answers are grounded in this paper and cite their sources.
How odd! A new class of non-nucleoside reverse transcriptase inhibitors with a 6-vinylpyrimidine scaffold (1) has been found to inhibit HIV-1 reverse transcriptase (RT) by competition with the nucleotide substrate after binding to the non-nucleoside inhibitor binding pocket of the enzyme. Molecular modeling studies have been performed to elucidate their peculiar behavior.
No takes yet. Share an insight, caveat, or question.
Maga et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: